• Like
hi
Upcoming SlideShare
Loading in...5
×

hi

  • 667 views
Uploaded on

 

More in: Technology , Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
667
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
27
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. - Dr. E. R. Venkata Subba Reddy
  • 2. Blood coagulation is part of an important  host defense mechanism termed hemostasis.  Hemostasis : arrest or stoppage of bleeding from a blood vessel.  Injury to a blood vessel initiates a series of reactions resulting in hemostasis.  Three stages : 1. Vasoconstriction 2. Formation of platelet plug 3. Coagulation of blood
  • 3. Injury to blood vessel ↓ Endothelial damage and collagen exposure VonWillebrand factor → I ↓ Activation of platelets FIBRINOGEN ↓ ↓ I Serotonin ADP + I I TX A2 I I ↓ I I Aggregation of I more platelets I I I ↓ ↓ Vasoconstriction platelet plug FIBRIN (clot) (STAGE 1) (STAGE 2) (STAGE 3)
  • 4. Definition : The process in which blood  looses its fluidity and becomes a jelly like mass few minutes after its shed out or collected in a container.  The so formed mass is called clot  The clot is a mesh of thin fibrils entangling the blood cells .These fibrils consist of fibrin. The fibrin is formed from fibrinogen.
  • 5. ENZYME CASCADE THEORY  - Factors in inactive proenzyme forms - Series of proenzyme-enzyme conversions ( Zymogen activation reactions ) - At each stage a precursor protein (zymogen) is converted to an active protease by cleavage of one or more peptide bonds - Helped by cofactors, calcium
  • 6. 3 STAGES  1. Formation of Prothrombin Activator 2. Conversion of Prothrombin to Thrombin 3. Conversion of Fibrinogen to Fibrin
  • 7. Two ways  1. Contact activation pathway (formerly known as the intrinsic pathway) 2. Tissue factor pathway (extrinsic pathway)
  • 8. Endothelial damage + collagen exposure I Kallikrein & I ↓ HMW kinogen I XII ------XIIa ↓ HMW kinogen Platelets ↓ XI ------XIa I Calcium I ↓ IX ------------ IXa ↓ VIII & Ca Phospholipid ↓ X------------------ Xa I I I ↓ ↓ PROTHROMBIN ACTIVATOR ( PTA ) (Xa + V + Ca +Phospholipid)
  • 9. Tissue trauma + Tissue thromboplastin ↓ Glycoprotein Phospholipid I VII --------------------------------- VIIa I Ca ↓ Phospholipid X ----------------------------------- Xa I Ca I Factor V I Thrombin ↓ Prothrombin activator (Xa + V + Ca +phospholipid)
  • 10. PROTHROMBIN ACTIVATOR I ↓ PROTHROMBIN-----------------→THROMBIN I ↓ FIBRINOGEN a ←------------------------- FIBRINOGEN I Polymerization I ↓ XIII & Ca LOOSE STRANDS OF FIBRIN-------------------------------→FIBRIN TIGHT BLOOD CLOT
  • 11. The substances necessary for clotting are  called clotting factors Thirteen identified  I – Fibrinogen II – Prothrombin III – Thromboplastin IV – Calcium V – Labile factor ( proaccelerin ) VI – presence not proved VII – Stable factor
  • 12. VIII – Anti hemophilic factor IX – Christmas factor X – Stuart-Prower factor XI – Plasma Thromboplastin antecedent XII – Hageman factor XIII – Fibrin stabilizing factor (Fibrinase)
  • 13. Calcium   Phospholipid  Vitamin K is an essential factor to a hepatic gamma-glutamyl carboxylase that adds a carboxyl group to glutamic acid residues on factors II, VII, IX and X, as well as protein S, Protein C and protein Z.
  • 14. Five mechanisms keep platelet activation and the  coagulation cascade in check. Protein C is a major physiological anticoagulant.  It is a vitamin K-dependent serine protease . Activated by thrombin with the help of thrombomodulin. The activated form, along with protein S and a phospholipid as cofactors, degrades Va and VIIIa. Antithrombin is a serine protease inhibitor  Tissue pathway factor inhibitor(TFPI)  Plasmin cleaves fibrin into fibrin degradation products  that inhibit excessive fibrin formation. Prostacyclin (PGI2) through cAMP inhibits platelet  activation
  • 15. Clot consists of entrapped  platelets, RBCs, WBCs within the fibrin meshwork.  Clot Retraction : after 30 to 45 min. -Clot contracts. Serum oozes out. -Actin, myosin and Thrombosthenin.  FIBRINOLYSIS : lysis in blood vessel. Requires plasmin (fibrinolysin)
  • 16. Commonly used: aPTT ( activated partial Thromboplastin time) - The  contact factor pathway PT (also used to determine INR)- The tissue factor  pathway Fibrinogen testing (often by the Clauss method)  Platelet count  Platelet function testing (often by PFA-100). 
  • 17. Others: Thrombin clotting time, Bleeding  time, Mixing test (whether an abnormality corrects if the patient's plasma is mixed with normal plasma), Coagulation factor assays, Antiphospholipid antibodies, D- dimer, Genetic tests (factor V leiden), Miscellaneous platelet function tests, Thromboelastography (TEG or ROTEM), Euglobulin lysis test(ELT), .
  • 18. Platelet disorders:  -Inborn or Acquired -congenital: > Glanzmann’s thrombasthenia - It is characterized by a defect in GPIIb/IIIa fibrinogen receptor complex, > Bernard-sourlier syndrome (abnormal glycoprotein Ib-IX-V complex), > Gray platelet syndrome(deficient α-granules), > Delta storage pool deficiency(deficient dense granules). -Acquired: MDS, ITP, TTP, HUS, PNH, DIC, HIT.
  • 19. HAEMOPHILIA: 3 main forms  - Hemophilia A : VIII deficiency - Hemophilia B : IX - Hemophilia C : XI  Von Willebrand disease : most common hereditary bleeding disorder . Def of vWF, that mediates glycoprotein Ib (GPIb) binding to collagen.
  • 20. Thrombosis is the pathological  development of blood clots. May form an embolus or cause occlusionocclusion by embolus or thrombus leads to ischemic necrosis of tissue.  Most cases of thrombosis are due to acquired extrinsic problems (surgery, cancer, immobility, obesity,)  A small proportion of people harbor predisposing conditions known collectively as Thrombophilia (antiphospholipid syndrome, factor V leiden).
  • 21. Adsorbent chemicals, such as zeolites, used for  use in sealing severe injuries quickly (traumatic bleeding secondary to gunshot wounds). Thrombin and fibrin glue are used surgically to  treat bleeding and to thrombose aneurysms. Desmopressin is used to improve platelet function  Prothrombin complex  concentrate, cryoprecipitate and fresh frozen plasma Recoombinant activated human factor VII is  increasingly popular in the treatment of major bleeding. Tranexemic acid and aminocaproic acid inhibit 
  • 22. Anticoagulants and anti-platelets.  Anti platelet agents : aspirin, clopidogrel, dipyridamole  and ticlopidine; the parenteral glycoprotein Iib/IIIa inhibitors are used during angioplasty Anticoagulants, Warfarin (and related coumarins) and  Heparin are the most commonly used. Warfarin affects the vitamin K-dependent clotting factors  (II, VII, IX,X). Heparin and related compounds increase the action of  antithrombin on thrombin and factor Xa. A newer class of drugs, the direct thrombin inhibitors, is  under development; some members are already in clinical use (such as lepirudin). compounds that interfere directly with the enzymatic  action of particular coagulation factors (e.g., rivaroxaban).
  • 23. --- Thankyou